Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Oligometastatic Peritoneal Metastasis

Tundra lists 1 Oligometastatic Peritoneal Metastasis clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07902648

Serplulimab, DOS and Lenvatinib Combine With PIPAC in the Oligometastatic Peritoneal Metastasis of Gastric/Gastroesophageal Junction Adenocarcinoma

This study is a prospective, multicenter, open-label, exploratory phase II clinical trial aimed at evaluating the efficacy and safety of serplulimab combined with DOS, lenvatinib, and PIPACS in patients with oligometastatic peritoneal metastases of gastric and gastroesophageal junction adenocarcinoma. A total of 42 patients diagnosed via laparoscopy with initially resectable gastric cancer accompanied by positive cytology in abdominal cavity washing solution and/or low-burden peritoneal metastases (peritoneal cancer index PCI ≤10) are planned to be enrolled to undergo serplulimab combined with DOS, lenvatinib, PIPACS, and surgical treatment.

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-29

Gastric/Gastroesophageal Junction Adenocarcinoma

Oligometastatic Peritoneal Metastasis